239 related articles for article (PubMed ID: 32739429)
1. Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin.
Cai S; Wang P; Xie T; Li Z; Li J; Lan R; Ding Y; Lu J; Ye J; Wang J; Li Z; Liu P
Pharmacol Res; 2020 Nov; 161():105104. PubMed ID: 32739429
[TBL] [Abstract][Full Text] [Related]
2. OGG1 regulates the level of symmetric dimethylation of histone H4 arginine-3 by interacting with PRMT5.
Zhou X; Wang W; Du C; Yan F; Yang S; He K; Wang H; Zhao A
Mol Cell Probes; 2018 Apr; 38():19-24. PubMed ID: 29409673
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cardiomyocyte hypertrophy by protein arginine methyltransferase 5.
Chen M; Yi B; Sun J
J Biol Chem; 2014 Aug; 289(35):24325-35. PubMed ID: 25012667
[TBL] [Abstract][Full Text] [Related]
4. KSHV encoded ORF59 modulates histone arginine methylation of the viral genome to promote viral reactivation.
Strahan RC; McDowell-Sargent M; Uppal T; Purushothaman P; Verma SC
PLoS Pathog; 2017 Jul; 13(7):e1006482. PubMed ID: 28678843
[TBL] [Abstract][Full Text] [Related]
5. The N
Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
[TBL] [Abstract][Full Text] [Related]
6. PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.
Zhao Q; Rank G; Tan YT; Li H; Moritz RL; Simpson RJ; Cerruti L; Curtis DJ; Patel DJ; Allis CD; Cunningham JM; Jane SM
Nat Struct Mol Biol; 2009 Mar; 16(3):304-311. PubMed ID: 19234465
[TBL] [Abstract][Full Text] [Related]
7. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3.
Shailesh H; Siveen KS; Sif S
J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997
[TBL] [Abstract][Full Text] [Related]
8. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Chen H; Lorton B; Gupta V; Shechter D
Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
[TBL] [Abstract][Full Text] [Related]
9. Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.
Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B
Sci Rep; 2015 Nov; 5():15494. PubMed ID: 26563484
[TBL] [Abstract][Full Text] [Related]
10. MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.
Saha K; Adhikary G; Eckert RL
J Invest Dermatol; 2016 Jan; 136(1):214-224. PubMed ID: 26763441
[TBL] [Abstract][Full Text] [Related]
11. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
12. PRMT5-mediated histone H4 arginine-3 symmetrical dimethylation marks chromatin at G + C-rich regions of the mouse genome.
Girardot M; Hirasawa R; Kacem S; Fritsch L; Pontis J; Kota SK; Filipponi D; Fabbrizio E; Sardet C; Lohmann F; Kadam S; Ait-Si-Ali S; Feil R
Nucleic Acids Res; 2014 Jan; 42(1):235-48. PubMed ID: 24097435
[TBL] [Abstract][Full Text] [Related]
13. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
14. Alpha-synuclein promotes PRMT5-mediated H4R3me2s histone methylation by interacting with the BAF complex.
Nakamura T; Sugeno N; Hasegawa T; Ikeda K; Yoshida S; Ishiyama S; Sato K; Takeda A; Aoki M
FEBS J; 2024 May; 291(9):1892-1908. PubMed ID: 38105619
[TBL] [Abstract][Full Text] [Related]
15. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.
Chung J; Karkhanis V; Baiocchi RA; Sif S
J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941
[TBL] [Abstract][Full Text] [Related]
16. The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N
Gao XQ; Zhang YH; Liu F; Ponnusamy M; Zhao XM; Zhou LY; Zhai M; Liu CY; Li XM; Wang M; Shan C; Shan PP; Wang Y; Dong YH; Qian LL; Yu T; Ju J; Wang T; Wang K; Chen XZ; Wang YH; Zhang J; Li PF; Wang K
Nat Cell Biol; 2020 Nov; 22(11):1319-1331. PubMed ID: 33020597
[TBL] [Abstract][Full Text] [Related]
17. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.
Zhang B; Dong S; Li Z; Lu L; Zhang S; Chen X; Cen X; Wu Y
J Transl Med; 2015 Nov; 13():349. PubMed ID: 26541651
[TBL] [Abstract][Full Text] [Related]
18. PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression.
Cai S; Liu R; Wang P; Li J; Xie T; Wang M; Cao Y; Li Z; Liu P
Front Pharmacol; 2020; 11():600627. PubMed ID: 33424610
[TBL] [Abstract][Full Text] [Related]
19. PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression.
Liu M; Yao B; Gui T; Guo C; Wu X; Li J; Ma L; Deng Y; Xu P; Wang Y; Yang D; Li Q; Zeng X; Li X; Hu R; Ge J; Yu Z; Chen Y; Chen B; Ju J; Zhao Q
Theranostics; 2020; 10(10):4437-4452. PubMed ID: 32292506
[TBL] [Abstract][Full Text] [Related]
20. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5.
Fulton MD; Dang T; Brown T; Zheng YG
Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
